呼吸 & Immunology
Home / 澳门葡京赌博游戏的治疗领域 /呼吸 & Immunology
澳门葡京赌博游戏的承诺
有五十年的经验, 澳门葡京赌博游戏是呼吸护理领域的领导者,也是免疫学领域的颠覆者. We are committed to transforming care for some of the most debilitating and chronic respiratory and immune-mediated diseases. 澳门葡京赌博游戏的吸入和生物药物组合, 以及澳门葡京赌博游戏未来的管道, 寻求解决患者今天面临的挑战和大量未满足的医疗需求. 通过遵循科学, 澳门葡京赌博游戏专注于可持续地解决棘手和复杂的未解决问题. 澳门葡京赌博游戏的方法包括针对潜在的生物学, developing effective new drug modalities and combinations and applying a precision medicine approach from the start of discovering medicines, 一切都是在驾驶时提前发现的, 诊断与干预.
澳门葡京赌博游戏的重点领域
We are focused on chronic respiratory diseases including asthma and 慢性阻塞性肺疾病 (COPD), 以及免疫驱动的疾病,比如狼疮. 澳门葡京赌博游戏遵循科学来解决棘手和复杂的问题, unsolved problems - targeting the underlying biology and developing effective new drug modalities and combinations with the ultimate ambition of achieving disease modification and clinical remission.
点击以下链接,了解更多澳门葡京赌博游戏关注的领域:
Our people
We are an established leader in 呼吸 medicine and a disruptor in Immunology and we invest in and value our people. 澳门葡京赌博游戏的定位是在澳门葡京赌博游戏的研究中遵循科学, 同时也解决了呼吸和免疫介导疾病的治疗和管理问题. 澳门葡京赌博游戏的文化植根于诚信, 包容, 澳门葡京赌博游戏致力于加入和支持澳门葡京赌博游戏生活和工作的社区.
呼吸 & 免疫学团队由:
在呼吸公司工作是一个激动人心的时刻 & Immunology, as we continue to work towards transforming care for some of the most debilitating and chronic respiratory and immune-mediated diseases. By targeting the underlying biology and applying a precision medicine approach from the start of discovering medicines, 澳门葡京赌博游戏的目标是超越症状控制,改变疾病, 缓解和一天, cure.
加入澳门葡京赌博游戏的团队
澳门葡京赌博游戏的呼吸 & Immunology therapy area is driven by innovation and our commitment to make a real-life difference in patient’s lives. 这种差异从你开始. IDEA Pharma ranked us #1 on their Invention Index and #2 on their Innovation Index and we are recognised as a top employer in 2021/2022 by Forbes, 金融时报》 and Biospace. We need people like you who share our passion for science and determination to meet patients’ needs around the world.
Visit our 职业网站 and:
协作
Through collaboration and partnerships, we can accelerate positive change and outcomes for patients. 澳门葡京赌博游戏与领先的研究和学术机构合作, 公共卫生当局, 呼吸系统和免疫介导疾病的患者群体和专业组织.
国际呼吸联盟
这是澳门葡京赌博游戏致力于改变所有患者呼吸系统护理的一部分, 澳门葡京赌博游戏是国际呼吸联盟的创始伙伴之一. The Coalition aims to support the transformation of post-pandemic respiratory healthcare and reduce deaths from respiratory disease by one-third globally by 2030. This goal, which aligns with the fast-approaching deadline set for the United Nation’s 可持续发展目标1, will be delivered through the creation or update of national respiratory strategies which accelerate and scale adoption of good practice care models.
为COPD大声疾呼
世界再也不能忽视慢性阻塞性肺病.2 That is why we are working with leading respiratory groups and patient allies from around the world to make this disease a public health priority. This cross-industry and multi partnered campaign has one critical goal: to increase the awareness and understanding of COPD among policymakers and healthcare systems. 澳门葡京赌博游戏的共同目标是消除政策变化障碍,优化COPD护理.
Breathless
虽然澳门葡京赌博游戏对严重哮喘的理解取得了重要进展, there is still significant unmet need and too many people do not receive the treatment and care they deserve.3,4 By increasing awareness of the new evidence on the continuing impact of severe asthma on patients’ lives and linking these challenges with tangible good practice case studies solutions, this campaign aims to drive urgency among policymakers and healthcare professionals to help address the barriers that underpin suboptimal care.
打破过分依赖
Our mission is to eliminate asthma attacks and enable people with asthma to live life to the fullest. Through increasing awareness and motivating systems and clinical practice to implement evidence-based guidelines for optimal asthma care, the 打破过分依赖 campaign seeks to break the cycle of over-reliance on SABA inhalers for asthma treatment.
澳门葡京赌博游戏的药品
澳门葡京赌博游戏无法在本网站上提供澳门葡京赌博游戏处方药的详细信息, 遵守规定.澳门葡京赌博游戏的药品 are approved in individual countries for specific uses and the information we provide for patients is governed by local regulations. 在某些情况下, healthcare professionals and patients can visit local AstraZeneca websites to find out more about our medicines. 请注意,在一些国家,澳门葡京赌博游戏不允许提供太多, 有时是任何, 关于澳门葡京赌博游戏处方药的信息,所以你应该寻找其他值得信赖的来源. 一定要向医疗保健专业人员咨询有关药物的建议.
accolit, accolit, Vanticon
扎鲁司
Bevespi大气层
格隆/ formoterol延胡索酸酯
Breztri大气层
布地奈德/格隆/ formoterol延胡索酸酯
Bricanyl Respules
terbutaline
Bricanyl Turbuhaler
特布他林在干粉吸入器里
Daliresp / Daxas
roflumilast
Duaklir Genuair
aclidinium / formoterol
Eklira Genuair / Tudorza / Bretaris
aclidinium,一个LAMA
Fasenra
benralizumab
Oxis Turbuhaler
Oxis Turbuhaler
急性喘息性
布地奈德吸入混悬液
Pulmicort Turbuhaler
budesonide
Rhinocort
budesonide
Saphnelo
anifrolumab
Symbicort pMDI
布地奈德/ formoterol
Symbicort Turbuhaler
布地奈德/ formoterol
Tezspire
tezepelumab
R的管道&I
Our pipeline forms a robust portfolio of investigational therapies in varied stages of clinical development.
第三阶段/注册. refers to assets that are in Phase III or that have been submitted for regulatory approval and may include assets that are now launched in one or more major markets.
呼吸 & 免疫学(截至2024年4月25日)
Phase I
Phase I
Phase II
Phase III
Phase III
模块项目
模块项目
最新消息
References
1. 联合国. 可持续发展目标. 可在:http://www.un.org/sustainabledevelopment/sustainable-development-goals/. [最后访问日期:2022年8月].
2. 世界卫生组织. 慢性阻塞性肺病字幕新闻. 可在:http://www.who.int /新闻/说明书/细节/慢性阻塞性肺疾病(copd). [最后访问日期:2022年8月].
3. Chen S, et al. 系统的临床文献综述, humanistic, 与GINA第4步或第5步治疗无法控制的哮喘相关的经济负担. 当前医学研究意见. 2018;34:2075–2088
4. Peters SP, et al. 不受控制的哮喘:患病率、疾病负担和治疗选择的综述. Respir Med. 2006: 100 (7): 1139-51.
Veeva ID: Z4-51416
筹备日期:2022年12月